0
Skip to Content
MD IP
Services
Overseas patent firms
Corporates
Overflow support
Others
Testimonials
About me
Contact
Blog
md@md-ip.com
MD IP
Services
Overseas patent firms
Corporates
Overflow support
Others
Testimonials
About me
Contact
Blog
md@md-ip.com
Folder: Services
Back
Overseas patent firms
Corporates
Overflow support
Others
Testimonials
About me
Contact
Blog
md@md-ip.com
A guide to ‘further processing’ at the European Patent Office
EPO practice, EPO prosecution Michał Dąbrówka 31/07/2025 EPO practice, EPO prosecution Michał Dąbrówka 31/07/2025

A guide to ‘further processing’ at the European Patent Office

Beyond remedying missed deadlines, further processing can offer valuable flexibility during European patent prosecution. Learn how to leverage it effectively as part of a coordinated global filing strategy.

Read More
Parameters and (in)sufficiency of disclosure – T 2009/23
EPO case law, EPO oppositions and appeals, EPO T decisions Michał Dąbrówka 22/07/2025 EPO case law, EPO oppositions and appeals, EPO T decisions Michał Dąbrówka 22/07/2025

Parameters and (in)sufficiency of disclosure – T 2009/23

In T 2009/23, the Board of Appeal of the European Patent Office found that a key parameter in the main independent claim could not be reliably determined, leading to fatal insufficiency of disclosure.  Learn more in our latest article.

Read More
T 1065/23 – on novelty and inventive step of pea protein extracts
EPO case law, EPO T decisions, EPO practice Michał Dąbrówka 17/07/2025 EPO case law, EPO T decisions, EPO practice Michał Dąbrówka 17/07/2025

T 1065/23 – on novelty and inventive step of pea protein extracts

T 1065/23 from the EPO’s Technical Board of Appeal illustrates how targeted experimental evidence can make or break product-by-process claims in the chemical field. Learn more in our latest article.

Read More
T 1561/23 - G 1/24 in action
EPO case law, EPO G decisions, EPO T decisions Michał Dąbrówka 10/07/2025 EPO case law, EPO G decisions, EPO T decisions Michał Dąbrówka 10/07/2025

T 1561/23 - G 1/24 in action

In T 1561/23, the Technical Board of Appeal of the European Patent Office applied the principles of G 1/24 on using the description to interpret patent claims. Learn the key takeaways from the decision.

Read More
G 1/23 - reproducibility not a requirement for a commercial product to be prior art
EPO case law, EPO G decisions, EPO oppositions and appeals Michał Dąbrówka 03/07/2025 EPO case law, EPO G decisions, EPO oppositions and appeals Michał Dąbrówka 03/07/2025

G 1/23 - reproducibility not a requirement for a commercial product to be prior art

The Enlarged Board of Appeal finds in G 1/23 that non-reproducible commercial products are part of the state of the art. Learn the key takeaways here.

Read More
Using ‘PACE’ at the EPO
EPO practice, EPO prosecution Michał Dąbrówka 11/06/2025 EPO practice, EPO prosecution Michał Dąbrówka 11/06/2025

Using ‘PACE’ at the EPO

Need faster patent prosecution in Europe? This guide explains how to use the European Patent Office’s PACE programme to accelerate search and examination timelines. Learn key requirements, risks, and strategic considerations from a European and UK patent attorney.

Read More
Older Posts
Dark blue banner showing a white stylized dopamine molecule graphic to the left of the text “MD” in orange and “IP” in white.

Regulated by IP Reg.

Business Address

Zlota 75A/7
00-819, Warsaw
Poland

Contact

md@md-ip.com
+48 796 328 597